Preoperative criterion identifying a low-risk group for lymph node metastasis in intrahepatic cholangiocarcinoma

Tomoaki Yoh, Etsuro Hatano, Satoru Seo, Hiroaki Terajima, Yoichiro Uchida, Kojiro Taura, Kentaro Yasuchika, Shinji Uemoto

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Abstract

Background: Imaging study cannot identify patients with potential low-risk for lymph node (LN) metastasis in intrahepatic cholangiocarcinoma (ICC). The purpose of this study was to identify a low-risk group for LN metastasis in ICC using preoperatively available factors. Methods: Data from 127 consecutive patients, who underwent curative intent surgery for ICC at Kyoto University Hospital and Kitano Hospital between 2002 and 2016, were retrospectively analyzed. By using only preoperative data, multiple linear regression model for predicting LN metastasis was developed. Results: Forty-three patients exhibited LN metastasis (33.9%). Serum CA19-9 levels ≥37 IU/ml, ICC with hilar invasion, and LN swelling were identified as independent preoperative predictors of LN metastasis. The prediction model for LN metastasis using these three factors revealed good discrimination (area under the receiver operating characteristics curve 0.874, P < 0.001). Negative for all three factors (i.e. CA19-9 levels <37 IU/ml, peripheral ICC and no LN swelling) identified 35 patients (27.6%) as a low-risk group, with the false negative rate of 2.3%. Conclusions: We proposed a preoperative criterion for predicting LN metastasis, giving rise to the identification of ICC patients who showed a low-risk of LN metastasis.

Original languageEnglish
Pages (from-to)299-307
Number of pages9
JournalJournal of Hepato-Biliary-Pancreatic Sciences
Volume25
Issue number6
DOIs
Publication statusPublished - 06-2018
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Preoperative criterion identifying a low-risk group for lymph node metastasis in intrahepatic cholangiocarcinoma'. Together they form a unique fingerprint.

Cite this